Increased ampicillin resistance in Haemophilus influenzae in Northern Ireland hospitals

P G Murphy1, I Craig

  • 1Department of Bacteriology, Belfast City Hospital.

Insights

Ampicillin resistance in Haemophilus influenzae clinical isolates from Northern Ireland hospitals reached 15% in 1985-1986, double the national average. This resistance level remained stable by 1989, indicating a persistent public health concern.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Haemophilus influenzae is a significant cause of bacterial infections.
  • Ampicillin resistance in H. influenzae poses a treatment challenge.
  • Surveillance of antimicrobial resistance is crucial for public health.

Purpose of the Study:

  • To determine the prevalence of ampicillin resistance in clinical isolates of Haemophilus influenzae in Northern Ireland.
  • To compare resistance levels to national averages and previous findings.
  • To monitor resistance trends over time.

Main Methods:

  • Analysis of clinical isolates of Haemophilus influenzae from Northern Ireland hospitals.
  • Antimicrobial susceptibility testing for ampicillin.
  • Comparison with national data and historical reports.
  • Computerised monitoring of routine specimens.

Main Results:

  • 15% (29/193) of clinical isolates of H. influenzae were ampicillin resistant during 1985-1986.
  • This prevalence was double the national average for the same period.
  • Ampicillin resistance showed a 65% increase compared to a report three years prior.
  • Resistance levels were maintained by 1989.

Conclusions:

  • A high and sustained level of ampicillin resistance in H. influenzae was observed in Northern Ireland.
  • The findings highlight the need for ongoing surveillance and potential adjustments in treatment guidelines.
  • Further discussion on susceptibility to other antimicrobials is warranted.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...